His primary areas of investigation include Cerebrospinal fluid, Immunology, Central nervous system, Viral load and Neopterin. His Cerebrospinal fluid study combines topics in areas such as Sida and Virology. His research brings together the fields of Biomarker and Immunology.
As a part of the same scientific family, Magnus Gisslén mostly works in the field of Central nervous system, focusing on Degenerative disease and, on occasion, Neurology. In his work, Inflammation, Antibody and Chemotherapy is strongly intertwined with Immune system, which is a subfield of Neopterin. His study in Viral disease is interdisciplinary in nature, drawing from both Cognitive disorder, Immunopathology and Intensive care medicine.
His main research concerns Immunology, Cerebrospinal fluid, Internal medicine, Viral load and Neopterin. The concepts of his Cerebrospinal fluid study are interwoven with issues in Biomarker, Dementia, Central nervous system and Virology. His research investigates the connection between Dementia and topics such as Neurocognitive that intersect with issues in Neuropsychology.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology, Intensive care and Emtricitabine. He combines subjects such as Viremia, Acquired immunodeficiency syndrome, Confidence interval, Asymptomatic and Ritonavir with his study of Viral load. The various areas that Magnus Gisslén examines in his Neopterin study include Immune activation, Immune system and Albumin.
Magnus Gisslén mostly deals with Internal medicine, Immunology, Inflammation, Cerebrospinal fluid and Neopterin. His Internal medicine study incorporates themes from Gastroenterology, Endocrinology, Viral load and Intensive care. His research investigates the connection between Immunology and topics such as Dementia that intersect with problems in Biomarker.
His research in Inflammation intersects with topics in Macrophage and Disease. His Cerebrospinal fluid research is multidisciplinary, incorporating perspectives in T cell, White blood cell, Central nervous system and Antiretroviral therapy. His Neopterin research incorporates themes from Albumin and Immune activation.
His primary areas of investigation include Immunology, Internal medicine, Inflammation, Disease and Neopterin. His Immunology study combines topics from a wide range of disciplines, such as Cerebrospinal fluid, Central nervous system and Antiretroviral therapy. His Cerebrospinal fluid study integrates concerns from other disciplines, such as Viral envelope, Neurology, Microglia and Virology.
The Internal medicine study combines topics in areas such as Gastroenterology and Viral load. His studies deal with areas such as Confidence interval, Hazard ratio, Viremia and Acquired immunodeficiency syndrome as well as Viral load. His research in Neopterin tackles topics such as Albumin which are related to areas like Meningitis, Dysgeusia, White blood cell and Pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Updated research nosology for HIV-associated neurocognitive disorders
A. Antinori;G. Arendt;J. T. Becker;B. J. Brew.
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
Magnus Gisslén;Richard W. Price;Ulf Andreasson;Niklas Norgren.
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Bridel C;van Wieringen Wn;Zetterberg H;Tijms Bm.
JAMA Neurology (2019)
HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
Arvid Edén;Dietmar Fuchs;Lars Hagberg;Staffan Nilsson.
The Journal of Infectious Diseases (2010)
HIV-1 infection and cognitive impairment in the cART era: a review.
Judith Schouten;Paola Cinque;Magnus Gisslen;Peter Reiss.
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
Nelly Kanberg;Nelly Kanberg;Nicholas J. Ashton;Nicholas J. Ashton;Lars-Magnus Andersson;Lars-Magnus Andersson;Aylin Yilmaz;Aylin Yilmaz.
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
Magnus Gisslén;Richard W Price;Staffan Nilsson.
BMC Infectious Diseases (2011)
Cerebrospinal Fluid HIV Escape Associated with Progressive Neurologic Dysfunction in Patients on Antiretroviral Therapy with Well-Controlled Plasma Viral Load
Michael J. Peluso;Francesca Ferretti;Julia Peterson;Evelyn Lee.
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
Lars Hagberg;Paola Cinque;Magnus Gisslen;Bruce J Brew.
Aids Research and Therapy (2010)
Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.
Magnus Gisslén;Veronica Svedhem;Lena Lindborg;Leo Flamholc.
Hiv Medicine (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: